SOLIGENIX, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
SOLIGENIX, INC. (SNGX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $56.63 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-07
- SOLIGENIX, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $28.61K, a 0.75% increase year-over-year.
- SOLIGENIX, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $28.02K, a 12.06% decline year-over-year.
- SOLIGENIX, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $27.45K, a 11.98% decline year-over-year.
- SOLIGENIX, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $26.89K, a 11.93% decline year-over-year.
- SOLIGENIX, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $114.60K, a 5.19% decline from fiscal 2024.
- SOLIGENIX, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $120.87K, a 8.74% increase from fiscal 2023.
- SOLIGENIX, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $111.15K, a 1.38% decline from fiscal 2022.
- SOLIGENIX, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $112.71K, a 3.08% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $56.63K 10-Q · filed 2026-08-07 | $84.08K derived: sum of 3 quarters · filed 2026-08-07 | $110.97K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $28.02K 10-Q · filed 2026-05-08 | $55.48K derived: sum of 2 quarters · filed 2026-05-08 | $82.36K derived: sum of 3 quarters · filed 2026-05-08 | $110.76K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $27.45K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $54.34K derived: sum of 2 quarters · filed 2026-03-31 | $82.73K derived: sum of 3 quarters · filed 2026-08-07 | $114.60K 10-K · filed 2026-03-31 |
| 2025-09-30 | $26.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $55.28K derived: sum of 2 quarters · filed 2026-08-07 | $87.15K 10-Q · filed 2025-11-07 | $118.34K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $28.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $60.26K 10-Q · filed 2026-08-07 | $91.45K derived: sum of 3 quarters · filed 2026-08-07 | $121.98K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $31.87K 10-Q · filed 2026-05-08 | $63.05K derived: sum of 2 quarters · filed 2026-05-08 | $93.58K derived: sum of 3 quarters · filed 2026-05-08 | $123.47K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $31.18K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $61.72K derived: sum of 2 quarters · filed 2026-03-31 | $91.61K derived: sum of 3 quarters · filed 2026-03-31 | $120.87K 10-K · filed 2026-03-31 |
| 2024-09-30 | $30.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $60.42K derived: sum of 2 quarters · filed 2025-11-07 | $89.69K 10-Q · filed 2025-11-07 | $118.34K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $29.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $59.16K 10-Q · filed 2025-08-14 | $87.81K derived: sum of 3 quarters · filed 2025-08-14 | $115.88K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $29.27K 10-Q · filed 2025-05-09 | $57.92K derived: sum of 2 quarters · filed 2025-05-09 | $85.99K derived: sum of 3 quarters · filed 2025-05-09 | $113.48K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $28.65K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $56.72K derived: sum of 2 quarters · filed 2025-03-21 | $84.22K derived: sum of 3 quarters · filed 2025-03-21 | $111.15K 10-K · filed 2025-03-21 |
| 2023-09-30 | $28.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $55.56K derived: sum of 2 quarters · filed 2024-11-08 | $82.50K 10-Q · filed 2024-11-08 | $108.89K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $27.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $54.43K 10-Q · filed 2024-08-09 | $80.82K derived: sum of 3 quarters · filed 2024-08-09 | $106.67K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $26.94K 10-Q · filed 2024-05-10 | $53.32K derived: sum of 2 quarters · filed 2024-05-10 | $79.17K derived: sum of 3 quarters · filed 2024-05-10 | $108.72K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $26.39K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $52.24K derived: sum of 2 quarters · filed 2024-03-15 | $81.79K derived: sum of 3 quarters · filed 2024-03-15 | $112.71K 10-K · filed 2024-03-15 |
| 2022-09-30 | $25.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $55.40K derived: sum of 2 quarters · filed 2023-11-13 | $86.33K 10-Q · filed 2023-11-13 | $116.49K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $29.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $60.48K 10-Q · filed 2023-08-21 | $90.64K derived: sum of 3 quarters · filed 2023-08-21 | $120.07K derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-03-31 | $30.93K 10-Q · filed 2023-05-15 | $61.09K derived: sum of 2 quarters · filed 2023-05-15 | $90.52K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $30.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $59.59K derived: sum of 2 quarters · filed 2023-03-31 | $116.29K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $29.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $86.12K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $56.70K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |